Nonetheless, anti-immunoglobulin E (IgE) therapy is effective for antigen-sensitized patients and trigger avoidance is currently recommended as a major component of asthma self-management by the most recent national asthma guidelines [12]. This evidence concerns the gene IGHE and asthma.